This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 4442628 results found since Jan 2013.
Migraines: Sufferers could be at risk of another condition - what to do
Migraines can be debilitating and can have a negative impact on a person's day-to-day life. According to a new survey, suffering from migraines leaves one in four people suffering with another condition - depression.
Source: Daily Express - Health - September 7, 2019 Category: Consumer Health News Source Type: news
Pamela: No more colitis, acid reflux, hypertension, migraines, joint pains and 170 pounds lighter on the Wheat Belly lifestyle
Look at Pamela’s spectacular progress that began with the Wheat Belly 10-Day Grain Detox and posted on the Detox Facebook page, showing her standing in ONE LEG of her old pants! Her experience illustrates just how awful health, weight, and life can get on the wrong way of eating, but also just how dramatic the changes can be when you finally get it right.
“It’s a long one, but hang with me!
“I’ve been debating whether to share this picture or not… I found my ‘before’ pants and decided to see what would happen… I thought I’d take another picture after I put on some makeup and ...
Source: Wheat Belly Blog - November 13, 2019 Category: Cardiology Authors: Dr. Davis Tags: Open autoimmune Detox Inflammation joint pain Weight Loss wheat belly Source Type: blogs
FDA Approves New Drug For Migraine Sufferers
(CNN) — The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can’t take or don’t respond to migraine medications currently on the market.
The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers.
“Ubrelvy represents an important new option for the acute treatment of migraine in adults, as...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston FDA Migraines Source Type: news
Percutaneous Closure of a "Doughnut Leak" Around an Atrial Septal Occluder Device in a Patient With Recurrent Migraines.
Authors: Agasthi P, Graziano JN, Pophal SG
Abstract
A 10-year-old girl with pulmonary atresia status post transannular patch repair and secundum atrial septal defect (ASD) underwent percutaneous ASD closure 5 years earlier. There was improvement in arterial saturation from 86% to 98% with minimal residual right-to-left shunt. Despite subsequent medical therapy, she developed recurrent migraines, which led us to pursue percutaneous closure of the shunt.
PMID: 32865512 [PubMed - in process]
Source: The Journal of Invasive Cardiology - September 2, 2020 Category: Cardiology Tags: J Invasive Cardiol Source Type: research
Effect of circadian rhythm on the pain associated with preventive onabotulinumtoxinA injections for migraines.
Abstract
The aim of our research was to assess if the pain and discomfort following each quarterly onabotulinumtoxinA (BTA) injection given to prevent daily headaches/migraines is circadian time-dependent so as to determine the best administration time for least discomfort and minimal follow-up pain. A total of 61 diurnally active patients with a medical history of chronic migraine headaches and undergoing preventative BTA injection therapy for the first time were enrolled in the study. Patients were randomly assigned to morning or afternoon clinics, but had the ability to choose within the assigned clinic the inj...
Source: Chronobiology International - August 31, 2020 Category: Biology Authors: Packard A, Smotherman C, Jovanovic N Tags: Chronobiol Int Source Type: research
Valproic Acid in the Treatment of Migraines
This article briefly summarizes the therapies considered first line for abortive treatment in the setting of migraines and provides an overview of the primary literature describing the use of valproic acid in these patients.
Source: Advanced Emergency Nursing Journal - October 1, 2020 Category: Emergency Medicine Tags: APPLIED PHARMACOLOGY Source Type: research
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
Condition: Migraine Headache Interventions: Behavioral: TENACITY Telehealth Cognitive Behavioral Therapy for Migraines; Behavioral: Usual Care Outpatient Cognitive Behavioral Therapy for Migraines Face to Face Sponsors: VA Quality Enhancement Research Intiative; VA Office of Research and Development Not yet recruiting
Source: ClinicalTrials.gov - November 3, 2020 Category: Research Source Type: clinical trials
